首页> 美国卫生研究院文献>Medical Archives >Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment

【2h】

Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment

机译：利妥昔单抗治疗下SLE和RA患者的NK（CD16 + 56 +）和B细胞（CD19）受体分子的表达是可靠的临床反应生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Lately, the use of biological therapy in various autoimmune diseases is increasing. The ideal marker for monitoring the effects of modern therapy is still non-existent.

机译：近来，在各种自身免疫疾病中生物疗法的使用正在增加。监测现代疗法效果的理想标记仍然不存在。

著录项

期刊名称 Medical Archives
作者
Lamija Zecevic; Mevludin Mekic; Djemo Subasic; Majda Hadziabulic; Edmira Isak; Emina Subasic; Kenan Selmanovic;
展开▼
作者单位

展开▼
年(卷),期 2019(73),6
年度 2019
页码 -1
总页数 4
原文格式 PDF
正文语种
中图分类
关键词
Autoimmune disease; Biological drugs; B cells and NK cells; therapy;

机译：自身免疫性疾病;生物药物;B细胞和NK细胞;治疗;

相似文献

外文文献
中文文献
专利

1. B-NHL患者NK细胞中CD16ζ表达及利妥昔单抗与LAK细胞的联合抗瘤作用 [J] . 史艳侠, 张晓实, 夏建川, 癌症（英文版） . 2007,第008期
2. The expression profile of toll-like receptor signaling molecules in CD19(+) B cells from patients with primary immune thrombocytopenia [J] . Hua Fanli, Li Ying, Zhao Xin, Immunology Letters . 2016,第Null期

机译：原发性免疫性血小板减少症患者CD19（+）B细胞中Toll样受体信号分子的表达特征
3. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response [J] . García-LeónJ.A., López-GómezC., órpez-ZafraT., CNS drugs . 2014,第6期

机译：干扰素-β治疗的多发性硬化症患者淋巴细胞亚群上的杀伤细胞免疫球蛋白样受体表达：评估为临床反应的生物标志物
4. CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS DIRECTED AGAINST CD19 (CTL019) INDUCE CLINICAL RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY CD19+LYMPHOMAS [J] . Levine B., Svoboda J., Nasta S. D., Cytotherapy . 2015,第6Suppla期

机译：CD19（CTL019）指导的嵌合抗原受体修饰的T细胞诱导患有复发或难治性CD19 +淋巴瘤的患者的临床反应
5. Angiogenic Hyaluronan Oligosaccharides interact with Endothelial Cell CD44 to Upregulate Expression of Adhesion Molecules, VEGF Receptors and IL-8 [C] . West DC, Wilson J, Lagoumintzis G., NATO Advanced Study Institute on Vascular Endothelium : Mechanisms of Cell Signaling . 1999

机译：血管生成透明质酸寡糖与内皮细胞CD44相互作用以上调粘附分子，VEGF受体和IL-8的表达
6. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21) and co-signaling molecule, CD19 in cattle [D] . Pringle, Eric S. 2011

机译：牛中补体受体1（CR1 / CD35）和2（CR2 / CD21）和共信号分子CD19的表达
7. Cell adhesion molecules as potential biomarkers of nephritis damage and accelerated atherosclerosis in patients with SLE [O] . S Skeoch, S Haque, P Pemberton, -1

机译：细胞粘附分子可作为SLE患者肾炎损伤和加速动脉粥样硬化的潜在生物标志物
8. Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment [O] . Lamija Zecevic, Mevludin Mekic, Djemo Subasic, 2019

机译：NK（CD16 + 56 +）和B细胞（CD19）受体分子的表达为Rituximab治疗下SLE和RA患者的可靠临床反应生物标志物

Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment

摘要

著录项

相似文献

相关主题

期刊订阅